Repeated peripheral administrations of CpG oligodeoxynucleotides lead to sustained CNS immune activation

被引:3
作者
Wagner, Isabella [1 ]
Sethi, Shneh [2 ]
Xiang, Wei [1 ]
Giese, Armin [1 ]
Ebner, Sabine [1 ]
Kretzschmar, Hans [1 ]
机构
[1] Univ Munich, Ctr Neuropathol & Prion Res, D-81377 Munich, Germany
[2] Univ Saarland, Inst Med Microbiol & Hyg, D-6650 Homburg, Germany
关键词
D O I
10.1080/08923970701675028
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bacterial DNA containing CpG motifs activates cells of the innate immune system. In this study, we examined the effects of multiple peripheral bacterial DNA-mediated CNS innate immune stimulation. To study this issue, we repeatedly peripherally administered synthetic CpG-oligodeoxynucleotides (CpG-ODN) and assayed effects on CNS-associated TNF-alpha (TNF alpha) and C1q mRNA levels. We for the first time accounted for frequency of CpG-ODN administration and time kinetics of mRNA expression. We were able show that multiple intraperitoneal CpG-ODN administrations have a sustainable effect on immune effectors of the brain and stimulate TNF alpha mRNA secretion even up to 7 days after the last CpG-ODN application. This could on the one hand indicate a depot effect after multiple peripheral CpG-ODN administrations, however, it could also indicate that the cell producing TNF alpha mRNA remains activated for the indicated time period. Furthermore, elevated mRNA levels of C1q were observed, possibly indicating microglial activation after multiple peripheral bacterial DNA administrations. In this study, we have correlated frequency of CpG-ODN administrations with CNS-associated TNF alpha mRNA levels and show that multiple peripheral administrations of CpG-ODN lead to a sustained level of a Th1-associated cytokine in the brain. These Findings indicate that the repeated peripherial administration of CpG oligodeoxynucleotides offer a therapeutical possibility for CNS-associated infections and tumors.
引用
收藏
页码:413 / 424
页数:12
相关论文
共 25 条
[1]  
Baines J, 2003, CLIN CANCER RES, V9, P2693
[2]  
Carpentier AF, 2000, CLIN CANCER RES, V6, P2469
[3]  
CHAO CC, 1994, J IMMUNOL, V152, P1246
[4]   Decreased cytomegalovirus expression following proinflammatory cytokine treatment of primary human astrocytes [J].
Cheeran, MCJ ;
Hu, SX ;
Gekker, G ;
Lokensgard, JR .
JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :926-933
[5]   Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat [J].
Colburn, RW ;
DeLeo, JA ;
Rickman, AJ ;
Yeager, MP ;
Kwon, P ;
Hickey, WF .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 79 (02) :163-175
[6]   Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors [J].
El Andaloussi, Abdeljabar ;
Sonabend, Adam M. ;
Han, Yu ;
Lesniak, Maciej S. .
GLIA, 2006, 54 (06) :526-535
[7]  
Giese A, 1998, BRAIN PATHOL, V8, P449
[8]   Innate immune recognition [J].
Janeway, CA ;
Medzhitov, R .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :197-216
[9]   EXPRESSION OF COMPLEMENT C1QB AND C4 MESSENGER-RNAS DURING RAT-BRAIN DEVELOPMENT [J].
JOHNSON, SA ;
PASINETTI, GM ;
FINCH, CE .
DEVELOPMENTAL BRAIN RESEARCH, 1994, 80 (1-2) :163-174
[10]   Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection [J].
Klinman, DM ;
Conover, J ;
Coban, C .
INFECTION AND IMMUNITY, 1999, 67 (11) :5658-5663